Srinivas Akkaraju - 01 Jul 2024 Form 4/A - Amendment Insider Report for ALUMIS INC. (ALMS)

Role: Director
Signature: /s/ Srinivas Akkaraju
Issuer symbol: ALMS
Transactions as of: 01 Jul 2024
Net transactions value: +$25,000,000
Form type: 4/A - Amendment
Filing time: 27 Aug 2024, 16:10:05 UTC
Date Of Original Report: 01 Jul 2024
Previous filing: 01 Jul 2024
Next filing: 18 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALMS	Common Stock	Purchase	$25,000,000	+1,562,500	+92%	$16.00	3,266,498	01 Jul 2024	By Samsara BioCapital, L.P.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original Form 4 inadvertently omitted the purchase of shares by Samsara in the Issuer's initial public offering.
F2	Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.

Content

The original Form 4 inadvertently omitted the purchase of shares by Samsara in the Issuer's initial public offering.

Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.